Ensitrelvir Patent Expiration
Ensitrelvir was first introduced by Shionogi Inc
Ensitrelvir Patents
Given below is the list of patents protecting Ensitrelvir, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Xocova | US11814368 | Triazine Derivatives Having Virus Replication Inhibitory Activity And Pharmaceutical Composition Comprising The Same | May 01, 2042 | Shionogi |
| Xocova | US12559474 | Triazine Derivatives Having Virus Replication Inhibitory Activity And Pharmaceutical Composition Comprising The Same | May 01, 2042 | Shionogi |
| Xocova | US9150546 | Triazine Derivative And Pharmaceutical Composition Comprising The Same | Dec 12, 2030 | Shionogi |
Ensitrelvir's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List